Guo Yu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Diffuse Large B Cell Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

CPT: pharmacometrics & systems pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Guo-Fu Li, Yu-Wei Qiao, Ai-Jia Guan, Guo Yu
Informative Censoring of Progression-Free Survival Data in TROPiCS-02 Trial: An Unrecognized Bias. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Guo Yu, Na Zhang, Ai-Jia Guan, Yu-Wei Qiao, Guo-Fu Li
Validity of Meta-Analytical Estimates and Hazard Ratios Quantifying Survival Benefit of Immunochemotherapy in Low PD-L1-Expressing Esophageal Squamous Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Guo-Fu Li, Yu-Wei Qiao, Ai-Jia Guan, Guo Yu
Informative Censoring of Progression-Free Survival Data in the TROPiCS-02 Trial: An Unrecognized Bias. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Guo-Fu Li, Yu-Wei Qiao, Ai-Jia Guan, Guo Yu
Informative Censoring of Progression-Free Survival Data in the TROPiCS-02 Trial: An Unrecognized Bias. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (8) (2023)
Dan-Na Wu, Guo Yu, Guo-Fu Li
Reproducing prolonged time to peak bisoprolol concentration by PBPK modeling with lysosomal trapping in enterocytes. CPT: pharmacometrics & systems pharmacology 11 (1) (2022)
Dan-Na Wu, Guo-Fu Li, Guo Yu
Use of proton pump inhibitors and adverse clinical outcomes. British journal of clinical pharmacology 88 (5) (2021)
Guo-Fu Li, Xiao-Xiao An, Yichao Yu, Li-Rong Jiao, Daniele Canarutto, Guo Yu, Guangji Wang, Dan-Na Wu, Yin Xiao
Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis. Gut 70 (9) (2020)